SCHEMBL313500

SCHEMBL313500

[c]1c(-c2cccc3c2Cc2ccccc2-3)ccc2c1Cc1ccccc1-2

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PNMT P11086 1/20 0.44
NPC1 O15118 3/20 0.39
RAB9A P51151 3/20 0.39
HTR7 P34969 2/20 0.36
HTR2B P41595 2/20 0.36
KDM4E B2RXH2 2/20 0.36
ALDH1A1 P00352 2/20 0.36
MAPT P10636 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
LMNA P02545 1/20 0.36
HPGD P15428 1/20 0.36
PGR P06401 1/20 0.35
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
CA4 P22748 1/20 0.33
CA6 P23280 1/20 0.33
MAOA P21397 1/20 0.33
DRD2 P14416 2/20 0.33
DRD4 P21917 1/20 0.33
DRD3 P35462 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1029595 0.81 KDM4E (0.34) PNMTNPC1RAB9AHTR7KDM4E
SCHEMBL3443207 0.80 ADORA2A (0.38) PNMTNPC1RAB9AHTR7HTR2B
SCHEMBL2965677 0.80 ALDH1A1 (0.36) PNMTNPC1RAB9AKDM4EALDH1A1
SCHEMBL2974521 0.80 KDM4E (0.36) PNMTNPC1RAB9AHTR7KDM4E
SCHEMBL217877 0.80 ALDH1A1 (0.36) NPC1RAB9AHTR2BKDM4EALDH1A1
SCHEMBL2971770 0.80 KDM4E (0.33) PNMTNPC1RAB9AKDM4EALDH1A1
SCHEMBL2974302 0.80 KDM4E (0.33) PNMTNPC1RAB9AKDM4EALDH1A1
SCHEMBL216860 0.79 ALDH1A1 (0.38) PNMTNPC1RAB9AHTR2BKDM4E
SCHEMBL524602 0.78 PNMT (0.63) PNMTNPC1RAB9AHTR7HTR2B
SCHEMBL30103334 0.78 PNMT (0.63) PNMTNPC1RAB9AHTR7HTR2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130237719-A1 Preparation and Use of Tetrasubstituted Fluorenyl Catalysts for Polymerization of Olefins FINA TECHNOLOGY, INC. (US) 2013-09-12 US disclosed
US-20120095175-A1 PREPARATION AND USE OF TETRASUBSTITUTED FLUORENYL CATALYSTS FOR POLYMERIZATION OF OLEFINS FINA TECHNOLOGY, INC. (US) 2012-04-19 US disclosed
US-8093418-B2 Metallocenes; for production of ethylene/propylene homo-/copolymers FINA TECHNOLOGY, INC. (US) 2012-01-10 US disclosed
EP-1915401-A2 PREPARATION AND USE OF TETRASUBSTITUTED FLUORENYL CATALYSTS FOR POLMERIZATION OF OLEFINS FINA TECHNOLOGY, INC. (US) 2008-04-30 EP disclosed
US-7335711-B2 Preparation and use of tetrasubstituted fluorenyl catalysts for polymerization of olefins FINA TECHNOLOGY, INC. (US) 2008-02-26 US disclosed
US-20080026935-A1 Preparation and Use of Tetrasubstituted Fluorenyl Catalysts for Polymerization of Olefins FINA TECHNOLOGY, INC. (US) 2008-01-31 US disclosed
WO-2007022244-A2 PREPARATION AND USE OF TETRASUBSTITUTED FLUORENYL CATALYSTS FOR POLMERIZATION OF OLEFINS FINA TECHNOLOGY, INC. (US) 2007-02-22 WO disclosed
US-20070043183-A1 Preparation and use of tetrasubstituted fluorenyl catalysts for polymerization of olefins FINA TECHNOLOGY, INC. 2007-02-22 US disclosed
CN-1079406-C Mesoscopic organopolysiloxane particles with chemically bonded metal compounds WACKER CHEMIE GMBH (DE) 2002-02-20 CN disclosed
US-6008309-A CROSSLINKED ORGANOPOLYSILOXANE PARTICLES OF UNIFORM PARTICLE SIZE DISTRIBUTION HAVING CHEMICALLY BONDED METALS, SOLUBLE IN ORGANIC SOLVENTS SUCH AS METHYLENE CHLORIDE, PENTANE, ACETONE, ETHANOL AND WATER; USE IN CATALYST SYSTEMS WACKER-CHEMIE GMBH (DE) 1999-12-28 US disclosed
CN-1198170-A Mesoscopic organopolysiloxane particles with chemically bonded metal compounds WACKER CHEMIE GMBH (DE) 1998-11-04 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130237719-A1 Preparation and Use of Tetrasubstituted Fluorenyl Catalysts for Polymerization of Olefins SFN, FANCF, B2M PNMT 1770/4885NPC1 2895/4885RAB9A 2268/4885
US-20120095175-A1 PREPARATION AND USE OF TETRASUBSTITUTED FLUORENYL CATALYSTS FOR POLYMERIZATION OF OLEFINS PYM1, SFN, FANCF PNMT 1006/4885NPC1 2945/4885RAB9A 1898/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.